{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:25:33Z","timestamp":1791318333767,"version":"4.3.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Malignant reproductive system tumors significantly impact the physical and mental health of adolescent and young adult males (AYAMs, aged 15\u201349 years), particularly their fertility. In recent years, the incidence of testicular and prostate cancer in this population has risen, while early diagnosis and treatment remain challenging. However, global epidemiological data on AYAMs are limited. This study aims to evaluate global trends in the incidence and burden of testicular and prostate cancers among AYAMs from 1990 to 2021, using data from the Global Burden of Disease (GBD) 2021 study, to address the research gap and inform public health strategies. We extracted data on the incidence and disability-adjusted life years (DALYs) for testicular and prostate cancer in adolescents and young adult males (AYAMs) aged 15\u201349 years from the 2021 Global Burden of Disease (GBD) database, covering 204 countries and territories from 1990 to 2021. As the GBD 2021 database only includes data for testicular cancer (ICD-10 code C62) and prostate cancer (ICD-10 code C61), other male reproductive system cancers, such as penile and epididymal cancer, were excluded. To analyze temporal trends, we applied the estimated annual percentage change (EAPC) method using linear regression models to calculate age-standardized incidence and DALY rates. Additionally, Spearman\u2019s rank correlation was used to assess the relationship between age-standardized rates and the Socio-Demographic Index (SDI) for each country and region in 2021. In 2021, a total of 94,229 new cases of male reproductive system cancers were reported globally among AYAMs. From 1990 to 2021, the global age-standardized incidence rate significantly increased (EAPC\u2009=\u20091.38), while the age-standardized DALY rate exhibited a downward trend (EAPC = -0.26). Both testicular cancer and prostate cancer showed a consistent increase in age-standardized incidence rates, while their age-standardized DALY rates declined. Testicular cancer represented a significantly higher proportion of male reproductive system cancers in AYAMs globally compared to prostate cancer, with regional variations in the cancer burden. Additionally, the age-standardized incidence rates of both testicular and prostate cancers were positively correlated with the SDI, while the age-standardized DALY rate displayed a hill-shaped relationship with SDI. Over the past three decades, the incidence of testicular and prostate cancers among adolescents and young adult males (AYAMs) has steadily increased, accompanied by significant regional disparities in DALYs. To reduce the global burden of these cancers, particularly for AYAMs, targeted prevention strategies are crucial. These should include early screening, timely treatment, and public health education tailored to the unique needs of young males. In low- and middle-income countries, efforts should focus on improving health management, promoting physical activity, fostering healthy dietary habits, and enhancing access to early cancer screening for AYAMs. Early detection and intervention are essential for improving survival rates and minimizing the long-term effects of cancer, such as fertility issues and psychological impacts. Collaboration between governments, public health organizations, and social institutions is critical for advancing cancer prevention and control, with a focus on the specific health needs of AYAMs.<\/jats:p>","DOI":"10.1038\/s41598-025-07361-3","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T05:00:52Z","timestamp":1751432452000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Global trends in testicular and prostate cancer among adolescents and young adult males aged 15\u201349 years, 1990\u20132021: insights from the GBD study"],"prefix":"10.1038","volume":"15","author":[{"given":"Xinyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoguang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanyue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjiao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunchao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisheng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"issue":"1","key":"7361_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S1470-2045(21)00581-7","volume":"23","author":"Collaborators GaYaC","year":"2022","unstructured":"Collaborators GaYaC. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the global burden of disease study 2019. Lancet Oncol. 23 (1), 27\u201352. https:\/\/doi.org\/10.1016\/S1470-2045(21)00581-7 (2022).","journal-title":"Lancet Oncol."},{"issue":"2","key":"7361_CR2","doi-asserted-by":"publisher","first-page":"100096","DOI":"10.1016\/j.esmoop.2021.100096","volume":"6","author":"A Ferrari","year":"2021","unstructured":"Ferrari, A. et al. Adolescents and young adults (AYA) with cancer: a position paper from the AYA working group of the European society for medical oncology (ESMO) and the European society for paediatric oncology (SIOPE). ESMO Open Apr. 6 (2), 100096. https:\/\/doi.org\/10.1016\/j.esmoop.2021.100096 (2021).","journal-title":"ESMO Open Apr"},{"key":"7361_CR3","doi-asserted-by":"publisher","unstructured":"Smith, A. W. et al. Next steps for adolescent and young adult oncology workshop: An update on progress and recommendations for the future. Cancer 122(7). 988\u2013999. https:\/\/doi.org\/10.1002\/cncr.29870 (2016).","DOI":"10.1002\/cncr.29870"},{"issue":"11","key":"7361_CR4","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1093\/jnci\/djaa007","volume":"1","author":"S Gupta","year":"2020","unstructured":"Gupta, S. et al. International trends in the incidence of Cancer among adolescents and young adults. J. Natl. Cancer Inst.. 1 (11), 1105\u20131117. https:\/\/doi.org\/10.1093\/jnci\/djaa007 (2020).","journal-title":"J. Natl. Cancer Inst."},{"issue":"12","key":"7361_CR5","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S1470-2045(17)30677-0","volume":"18","author":"MM Fidler","year":"2017","unstructured":"Fidler, M. M. et al. Cancer incidence and mortality among young adults aged 20\u201339 years worldwide in 2012: a population-based study. Lancet Oncol Dec. 18 (12), 1579\u20131589. https:\/\/doi.org\/10.1016\/S1470-2045(17)30677-0 (2017).","journal-title":"Lancet Oncol Dec."},{"issue":"1","key":"7361_CR6","doi-asserted-by":"publisher","first-page":"e000049","DOI":"10.1136\/bmjonc-2023-000049","volume":"2","author":"J Zhao","year":"2023","unstructured":"Zhao, J. et al. Global trends in incidence, death, burden and risk factors of early-onset cancer from 1990 to 2019. BMJ Oncol. 2 (1), e000049. https:\/\/doi.org\/10.1136\/bmjonc-2023-000049 (2023).","journal-title":"BMJ Oncol."},{"issue":"4","key":"7361_CR7","doi-asserted-by":"publisher","first-page":"7230","DOI":"10.3390\/ijms16047230","volume":"31","author":"E Tvrda","year":"2015","unstructured":"Tvrda, E., Agarwal, A. & Alkuhaimi, N. Male reproductive cancers and infertility: a mutual relationship. Int J. Mol. Sci Mar. 31 (4), 7230\u20137260. https:\/\/doi.org\/10.3390\/ijms16047230 (2015).","journal-title":"Int J. Mol. Sci Mar."},{"key":"7361_CR8","doi-asserted-by":"publisher","unstructured":"Siegel, R. L., Giaquinto, A. N., Jemal, A. & Cancer statistics CA Cancer J Clin. Jan-Feb 2024;74(1):12\u201349. (2024). https:\/\/doi.org\/10.3322\/caac.21820","DOI":"10.3322\/caac.21820"},{"issue":"12","key":"7361_CR9","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1002\/cncr.30597","volume":"15","author":"AA Ghazarian","year":"2017","unstructured":"Ghazarian, A. A., Kelly, S. P., Altekruse, S. F., Rosenberg, P. S. & Mcglynn, K. A. Future of testicular germ cell tumor incidence in the united states: forecast through 2026. Cancer. 15 (12), 2320\u20132328. https:\/\/doi.org\/10.1002\/cncr.30597 (2017).","journal-title":"Cancer"},{"issue":"8","key":"7361_CR10","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.1097\/JS9.0000000000001603","volume":"1","author":"X Zhou","year":"2024","unstructured":"Zhou, X. et al. Trends in the global, regional, and National burden of testicular cancer from 1990 to 2019: an observational study with 30-year global data. Int J. Surg Aug. 1 (8), 4633\u20134647. https:\/\/doi.org\/10.1097\/JS9.0000000000001603 (2024).","journal-title":"Int J. Surg Aug"},{"issue":"1","key":"7361_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/andr.288","volume":"3","author":"AA Ghazarian","year":"2015","unstructured":"Ghazarian, A. A., Trabert, B., Devesa, S. S. & Mcglynn, K. A. Recent trends in the incidence of testicular germ cell tumors in the united States. Andrology. 3 (1), 13\u201318. https:\/\/doi.org\/10.1111\/andr.288 (2015).","journal-title":"Andrology"},{"issue":"1","key":"7361_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41572-018-0029-0","volume":"5","author":"L Cheng","year":"2018","unstructured":"Cheng, L. et al. Testicular cancer. Nat .Rev. Dis. Primers 5 (1), 29. https:\/\/doi.org\/10.1038\/s41572-018-0029-0 (2018).","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"31","key":"7361_CR13","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1200\/JCO.2017.73.4723","volume":"1","author":"T Tandstad","year":"2017","unstructured":"Tandstad, T. et al. Practice makes perfect: the rest of the story in testicular Cancer as a model curable neoplasm. J. Clin. Oncol.. 1 (31), 3525\u20133528. https:\/\/doi.org\/10.1200\/JCO.2017.73.4723 (2017).","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"7361_CR14","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.1097\/JS9.0000000000001603","volume":"110","author":"X Zhou","year":"2024","unstructured":"Zhou, X. et al. Trends in the global, regional, and National burden of testicular cancer from 1990 to 2019: an observational study with 30-year global data. Int. J. Surg. (London England). 110 (8), 4633\u20134647. https:\/\/doi.org\/10.1097\/JS9.0000000000001603 (2024).","journal-title":"Int. J. Surg. (London England)"},{"issue":"6","key":"7361_CR15","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.eururo.2013.11.004","volume":"65","author":"A Znaor","year":"2014","unstructured":"Znaor, A., Lortet-Tieulent, J., Jemal, A. & Bray, F. International variations and trends in testicular cancer incidence and mortality. Eur. Urol.. 65 (6), 1095\u20131106. https:\/\/doi.org\/10.1016\/j.eururo.2013.11.004 (2014).","journal-title":"Eur. Urol."},{"issue":"3","key":"7361_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71 (3), 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"7361_CR17","doi-asserted-by":"publisher","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E., Jemal, A. & Cancer Statistics CA Cancer J. Clin..71(1), 7\u201333. https:\/\/doi.org\/10.3322\/caac.21654 (2021).","DOI":"10.3322\/caac.21654"},{"issue":"1","key":"7361_CR18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.eururo.2019.08.005","volume":"77","author":"MB Culp","year":"2020","unstructured":"Culp, M. B., Soerjomataram, I., Efstathiou, J. A., Bray, F. & Jemal, A. Recent global patterns in prostate Cancer incidence and mortality rates. Eur. Urol.. 77 (1), 38\u201352. https:\/\/doi.org\/10.1016\/j.eururo.2019.08.005 (2020).","journal-title":"Eur. Urol."},{"issue":"5","key":"7361_CR19","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.eururo.2016.05.043","volume":"70","author":"MC Wong","year":"2016","unstructured":"Wong, M. C. et al. Global incidence and mortality for prostate cancer: analysis of Temporal patterns and trends in 36 countries. Eur. Urol.. 70 (5), 862\u2013874. https:\/\/doi.org\/10.1016\/j.eururo.2016.05.043 (2016).","journal-title":"Eur. Urol."},{"issue":"10258","key":"7361_CR20","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"17","author":"GBD Diseases","year":"2020","unstructured":"Diseases, G. B. D. & Injuries, C. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet 17 (10258), 1204\u20131222. https:\/\/doi.org\/10.1016\/S0140-6736(20)30925-9 (2020).","journal-title":"Lancet"},{"issue":"10440","key":"7361_CR21","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"18","author":"GBD Diseases","year":"2024","unstructured":"Diseases, G. B. D. & Injuries, C. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Lancet. 18 (10440), 2133\u20132161. https:\/\/doi.org\/10.1016\/S0140-6736(24)00757-8 (2024).","journal-title":"Lancet"},{"issue":"1","key":"7361_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1023\/a:1008953201688","volume":"11","author":"BF Hankey","year":"2000","unstructured":"Hankey, B. F. et al. Partitioning linear trends in age-adjusted rates. Cancer Causes Control. 11 (1), 31\u201335. https:\/\/doi.org\/10.1023\/a:1008953201688 (2000).","journal-title":"Cancer Causes Control"},{"issue":"1","key":"7361_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1023\/a:1023299520828","volume":"2","author":"BA Verhage","year":"2003","unstructured":"Verhage, B. A. & Kiemeney, L. A. Genetic susceptibility to prostate cancer: A review. Fam Cancer. 2 (1), 57\u201367. https:\/\/doi.org\/10.1023\/a:1023299520828 (2003).","journal-title":"Fam Cancer"},{"key":"7361_CR24","doi-asserted-by":"publisher","unstructured":"Rafikova, G., Gilyazova, I., Enikeeva, K., Pavlov, V. & Kzhyshkowska, J. Prostate cancer: genetics, epigenetics and the need for immunological biomarkers. Int J. Mol. Sci.. 14 (16). https:\/\/doi.org\/10.3390\/ijms241612797 (2023).","DOI":"10.3390\/ijms241612797"},{"key":"7361_CR25","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3389\/fendo.2019.00408","volume":"10","author":"L De Toni","year":"2019","unstructured":"De Toni, L. et al. Testicular cancer: genes, environment, hormones. Front. Endocrinol. (Lausanne). 10, 408. https:\/\/doi.org\/10.3389\/fendo.2019.00408 (2019).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"3","key":"7361_CR26","doi-asserted-by":"publisher","first-page":"257","DOI":"10.6004\/jnccn.2017.7046","volume":"16","author":"MA Zaid","year":"2018","unstructured":"Zaid, M. A. et al. Clinical and genetic risk factors for adverse metabolic outcomes in North American testicular Cancer survivors. J Natl. Compr. Canc Netw. 16 (3), 257\u2013265. https:\/\/doi.org\/10.6004\/jnccn.2017.7046 (2018).","journal-title":"J Natl. Compr. Canc Netw."},{"issue":"1","key":"7361_CR27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1001\/jama.2015.17703","volume":"5","author":"LA Mucci","year":"2016","unstructured":"Mucci, L. A. et al. Familial risk and heritability of Cancer among twins in nordic countries. JAMA. 5 (1), 68\u201376. https:\/\/doi.org\/10.1001\/jama.2015.17703 (2016).","journal-title":"JAMA"},{"issue":"1","key":"7361_CR28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/andr.293","volume":"3","author":"B Trabert","year":"2015","unstructured":"Trabert, B., Chen, J., Devesa, S. S., Bray, F. & Mcglynn, K. A. International patterns and trends in testicular cancer incidence, overall and by histologic subtype, 1973\u20132007. Andrology. 3 (1), 4\u201312. https:\/\/doi.org\/10.1111\/andr.293 (2015).","journal-title":"Andrology"},{"issue":"6","key":"7361_CR29","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.eururo.2012.02.054","volume":"61","author":"MM Center","year":"2012","unstructured":"Center, M. M. et al. International variation in prostate cancer incidence and mortality rates. Eur. Urol.. 61 (6), 1079\u20131092. https:\/\/doi.org\/10.1016\/j.eururo.2012.02.054 (2012).","journal-title":"Eur. Urol."},{"issue":"1","key":"7361_CR30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.euo.2021.07.006","volume":"5","author":"BA Mahal","year":"2022","unstructured":"Mahal, B. A. et al. Prostate Cancer Racial disparities: A systematic review by the prostate Cancer foundation panel. Eur Urol. Oncol.. 5 (1), 18\u201329. https:\/\/doi.org\/10.1016\/j.euo.2021.07.006 (2022).","journal-title":"Eur Urol. Oncol Feb"},{"issue":"41","key":"7361_CR31","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.15585\/mmwr.mm6941a1","volume":"16","author":"DA Siegel","year":"2020","unstructured":"Siegel, D. A., O\u2019neil, M. E., Richards, T. B., Dowling, N. F. & Weir, H. K. Prostate Cancer incidence and survival, by stage and Race\/Ethnicity - United states, 2001\u20132017. MMWR Morb. Mortal. Wkly. Rep. 16 (41), 1473\u20131480. https:\/\/doi.org\/10.15585\/mmwr.mm6941a1 (2020).","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"9","key":"7361_CR32","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s40618-022-01769-8","volume":"45","author":"F Cargnelutti","year":"2022","unstructured":"Cargnelutti, F. et al. Risk factors on testicular function in adolescents. J. Endocrinol. Invest. 45 (9), 1625\u20131639. https:\/\/doi.org\/10.1007\/s40618-022-01769-8 (2022).","journal-title":"J Endocrinol. Invest."},{"issue":"6","key":"7361_CR33","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s00345-016-1914-3","volume":"35","author":"SF Peisch","year":"2017","unstructured":"Peisch, S. F., Van Blarigan, E. L., Chan, J. M., Stampfer, M. J. & Kenfield, S. A. Prostate cancer progression and mortality: a review of diet and lifestyle factors. World J. Urol.. 35 (6), 867\u2013874. https:\/\/doi.org\/10.1007\/s00345-016-1914-3 (2017).","journal-title":"World J. Urol."},{"issue":"8","key":"7361_CR34","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1007\/s10552-009-9347-6","volume":"20","author":"AJ Littman","year":"2009","unstructured":"Littman, A. J. et al. Physical activity in adolescence and testicular germ cell cancer risk. Cancer Causes Control Oct. 20 (8), 1281\u20131290. https:\/\/doi.org\/10.1007\/s10552-009-9347-6 (2009).","journal-title":"Cancer Causes Control Oct."},{"issue":"12","key":"7361_CR35","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.6004\/jnccn.2019.0058","volume":"17","author":"T Gilligan","year":"2019","unstructured":"Gilligan, T. et al. Testicular cancer, version 2.2020, NCCN clinical practice guidelines in oncology. J. Natl. Compr. Canc. Netw. 17 (12), 1529\u20131554. https:\/\/doi.org\/10.6004\/jnccn.2019.0058 (2019).","journal-title":"J. Natl. Compr. Canc Netw."},{"issue":"5","key":"7361_CR36","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.eururo.2012.11.013","volume":"63","author":"EH Allott","year":"2013","unstructured":"Allott, E. H., Masko, E. M. & Freedland, S. J. Obesity and prostate cancer: weighing the evidence. Eur. Urol.. 63 (5), 800\u2013809. https:\/\/doi.org\/10.1016\/j.eururo.2012.11.013 (2013).","journal-title":"Eur. Urol."},{"issue":"11","key":"7361_CR37","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1002\/cncr.33426","volume":"1","author":"C Reiter-Brennan","year":"2021","unstructured":"Reiter-Brennan, C. et al. Fitness and prostate cancer screening, incidence, and mortality: results from the Henry Ford exercise testing (FIT) project. Cancer. 1 (11), 1864\u20131870. https:\/\/doi.org\/10.1002\/cncr.33426 (2021).","journal-title":"Cancer"},{"issue":"12","key":"7361_CR38","doi-asserted-by":"publisher","first-page":"e4834","DOI":"10.1210\/clinem\/dgab523","volume":"19","author":"EV Brauner","year":"2021","unstructured":"Brauner, E. V. et al. Endocrine disrupting chemicals and risk of testicular cancer: A systematic review and Meta-analysis. J. Clin. Endocrinol. Metab.. 19 (12), e4834\u2013e4860. https:\/\/doi.org\/10.1210\/clinem\/dgab523 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"7361_CR39","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s40618-022-01983-4","volume":"46","author":"R Modica","year":"2023","unstructured":"Modica, R., Benevento, E. & Colao, A. Endocrine-disrupting chemicals (EDCs) and cancer: new perspectives on an old relationship. J. Endocrinol. Invest.. 46 (4), 667\u2013677. https:\/\/doi.org\/10.1007\/s40618-022-01983-4 (2023).","journal-title":"J. Endocrinol. Invest."},{"issue":"Pt B","key":"7361_CR40","doi-asserted-by":"publisher","first-page":"112085","DOI":"10.1016\/j.envres.2021.112085","volume":"204","author":"A Lacouture","year":"2022","unstructured":"Lacouture, A., Lafront, C., Peillex, C., Pelletier, M. & Audet-Walsh, E. Impacts of endocrine-disrupting chemicals on prostate function and cancer. Environ. Res. Mar. 204 (Pt B), 112085. https:\/\/doi.org\/10.1016\/j.envres.2021.112085 (2022).","journal-title":"Environ Res Mar."},{"issue":"6","key":"7361_CR41","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/nrurol.2012.61","volume":"17","author":"KA Mcglynn","year":"2012","unstructured":"Mcglynn, K. A. & Trabert, B. Adolescent and adult risk factors for testicular cancer. Nat Rev. Urol Apr. 17 (6), 339\u2013349. https:\/\/doi.org\/10.1038\/nrurol.2012.61 (2012).","journal-title":"Nat Rev. Urol Apr"},{"issue":"1","key":"7361_CR42","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1001\/jamaoncol.2021.5143","volume":"1","author":"MS Leapman","year":"2022","unstructured":"Leapman, M. S. et al. Changes in prostate-Specific antigen testing relative to the revised US preventive services task force recommendation on prostate Cancer screening. JAMA Oncol Jan. 1 (1), 41\u201347. https:\/\/doi.org\/10.1001\/jamaoncol.2021.5143 (2022).","journal-title":"JAMA Oncol Jan"},{"key":"7361_CR43","doi-asserted-by":"publisher","unstructured":"Negoita, S. et al. Annual Report to the Nation on the Status of Cancer, part II: Recent changes in prostate cancer trends and disease characteristics. Cancer. 124(13), 2801\u20132814. https:\/\/doi.org\/10.1002\/cncr.31549 (2018).","DOI":"10.1002\/cncr.31549"},{"issue":"4","key":"7361_CR44","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.prnil.2015.09.001","volume":"3","author":"R Pakzad","year":"2015","unstructured":"Pakzad, R., Mohammadian-Hafshejani, A., Ghoncheh, M., Pakzad, I. & Salehiniya, H. The incidence and mortality of prostate cancer and its relationship with development in Asia. Prostate Int Dec. 3 (4), 135\u2013140. https:\/\/doi.org\/10.1016\/j.prnil.2015.09.001 (2015).","journal-title":"Prostate Int Dec."},{"issue":"5","key":"7361_CR45","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S1470-2045(08)70104-9","volume":"9","author":"SM Collin","year":"2008","unstructured":"Collin, S. M. et al. Prostate-cancer mortality in the USA and UK in 1975\u20132004: an ecological study. Lancet Oncol May. 9 (5), 445\u2013452. https:\/\/doi.org\/10.1016\/S1470-2045(08)70104-9 (2008).","journal-title":"Lancet Oncol May"},{"key":"7361_CR46","doi-asserted-by":"publisher","first-page":"37","DOI":"10.18632\/oncoscience.527","volume":"8","author":"A Bleyer","year":"2021","unstructured":"Bleyer, A., Spreafico, F. & Barr, R. Causation of increased prostate cancer in young men. Oncoscience 8, 37\u201339. https:\/\/doi.org\/10.18632\/oncoscience.527 (2021).","journal-title":"Oncoscience"},{"issue":"12","key":"7361_CR47","doi-asserted-by":"publisher","first-page":"e1371","DOI":"10.1634\/theoncologist.2019-0057","volume":"24","author":"NR Brand","year":"2019","unstructured":"Brand, N. R., Qu, L. G., Chao, A. & Ilbawi, A. M. Delays and barriers to Cancer care in Low- and Middle-Income countries: A systematic review. Oncologist Dec. 24 (12), e1371\u2013e1380. https:\/\/doi.org\/10.1634\/theoncologist.2019-0057 (2019).","journal-title":"Oncologist Dec."},{"issue":"2","key":"7361_CR48","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.socscimed.2008.03.038","volume":"67","author":"P Demakakos","year":"2008","unstructured":"Demakakos, P., Nazroo, J., Breeze, E. & Marmot, M. Socioeconomic status and health: the role of subjective social status. Soc Sci. Med Jul. 67 (2), 330\u2013340. https:\/\/doi.org\/10.1016\/j.socscimed.2008.03.038 (2008).","journal-title":"Soc Sci. Med Jul"},{"issue":"7","key":"7361_CR49","doi-asserted-by":"publisher","first-page":"4592","DOI":"10.1073\/pnas.072067999","volume":"99","author":"LH Einhorn","year":"2002","unstructured":"Einhorn, L. H. Curing metastatic testicular cancer. Proc. Natl. Acad. Sci. U S A. 99 (7), 4592\u20134595 (2002).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"7361_CR50","doi-asserted-by":"publisher","unstructured":"Mangone, L. et al. Impact of the COVID-19 pandemic on prostate Cancer diagnosis, staging, and treatment: A Population-Based study in Northern italy. Biology (Basel). Jul 4 (7). https:\/\/doi.org\/10.3390\/biology13070499 (2024).","DOI":"10.3390\/biology13070499"},{"key":"7361_CR51","doi-asserted-by":"publisher","first-page":"991330","DOI":"10.3389\/fcell.2022.991330","volume":"10","author":"S Belkahla","year":"2022","unstructured":"Belkahla, S., Nahvi, I., Biswas, S., Nahvi, I. & Ben Amor, N. Advances and development of prostate cancer, treatment, and strategies: A systemic review. Front. Cell. Dev. Biol. 10, 991330. https:\/\/doi.org\/10.3389\/fcell.2022.991330 (2022).","journal-title":"Front. Cell. Dev. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07361-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07361-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07361-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T05:00:53Z","timestamp":1751432453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07361-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7361"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-07361-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"5 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study is based on publicly available data from the GBD database, which is fully de-identified and aggregated. Ethical approval and consent to participate were not required, as this research did not involve human participants or personal data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This study is based on publicly available, de-identified data from the GBD database and does not involve any individual person\u2019s data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"23388"}}